172 related articles for article (PubMed ID: 32618472)
21. The unique molecular targets associated antioxidant and antifibrotic activity of curcumin in in vitro model of acute lung injury: A proteomic approach.
Shaikh SB; Najar MA; Prabhu A; Rex DAB; Chanderasekaran J; Behera SK; Modi PK; Prasad TSK; Bhandary YP
Biofactors; 2021 Jul; 47(4):627-644. PubMed ID: 33864298
[TBL] [Abstract][Full Text] [Related]
22. FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model.
Lv YQ; Cai GF; Zeng PP; Dhlamini Q; Chen LF; Chen JJ; Lyu HD; Mossahebi-Mohammadi M; Ahmadvand N; Bellusci S; Li X; Chen C; Zhang JS
Cells; 2022 Aug; 11(15):. PubMed ID: 35954241
[TBL] [Abstract][Full Text] [Related]
23. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
Cai Y; Kimura S
PLoS One; 2015; 10(11):e0142497. PubMed ID: 26559674
[TBL] [Abstract][Full Text] [Related]
24. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary Emphysema Cross-Linking with Pulmonary Fibrosis and Vice Versa: a Non-usual Experimental Intervention with Elastase and Bleomycin.
Cattani-Cavalieri I; Reis AG; Kennedy-Feitosa E; Pinho-Ribeiro V; Lanzetti M; Gitirana LB; Romana-Souza B; Porto LC; Valença SS
Inflammation; 2017 Oct; 40(5):1487-1496. PubMed ID: 28534139
[TBL] [Abstract][Full Text] [Related]
26. [The Study of the Effect and Mechanism of Glucagon Like Peptide-1 in Bleomycin-induced Pulmonary Fibrosis in Mice].
Liu M; Gou S; Chen HT; Chen ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):509-514. PubMed ID: 28752966
[TBL] [Abstract][Full Text] [Related]
27. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of curcumin on bleomycin-induced changes in lung glycoproteins.
Durairaj P; Venkatesan S; Narayanan V; Babu M
Mol Cell Biochem; 2020 Jun; 469(1-2):159-167. PubMed ID: 32350681
[TBL] [Abstract][Full Text] [Related]
29. Histopathological Correlations between Mediastinal Fat-Associated Lymphoid Clusters and the Development of Lung Inflammation and Fibrosis following Bleomycin Administration in Mice.
Elewa YHA; Ichii O; Takada K; Nakamura T; Masum MA; Kon Y
Front Immunol; 2018; 9():271. PubMed ID: 29497425
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
31. Abnormal mitochondrial iron metabolism damages alveolar type II epithelial cells involved in bleomycin-induced pulmonary fibrosis.
Shao M; Cheng H; Li X; Qiu Y; Zhang Y; Chang Y; Fu J; Shen M; Xu X; Feng D; Han Y; Yue S; Zhou Y; Luo Z
Theranostics; 2024; 14(7):2687-2705. PubMed ID: 38773980
[No Abstract] [Full Text] [Related]
32. Effect of preventive or therapeutic treatment with angiotensin 1-7 in a model of bleomycin-induced lung fibrosis in mice.
Rago F; Melo EM; Kraemer L; Galvão I; Cassali GD; Santos RAS; Russo RC; Teixeira MM
J Leukoc Biol; 2019 Sep; 106(3):677-686. PubMed ID: 31256436
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis.
Liang M; Wang J; Chu H; Zhu X; He H; Liu Q; Qiu J; Zhou X; Guan M; Xue Y; Chen X; Zou H
Mediators Inflamm; 2013; 2013():209179. PubMed ID: 23476100
[TBL] [Abstract][Full Text] [Related]
34. Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway.
Tao N; Li K; Liu J; Fan G; Sun T
Biochem Biophys Res Commun; 2021 Apr; 551():133-139. PubMed ID: 33735625
[TBL] [Abstract][Full Text] [Related]
35. IL-27 alleviates the bleomycin-induced pulmonary fibrosis by regulating the Th17 cell differentiation.
Dong Z; Lu X; Yang Y; Zhang T; Li Y; Chai Y; Lei W; Li C; Ai L; Tai W
BMC Pulm Med; 2015 Feb; 15():13. PubMed ID: 25888222
[TBL] [Abstract][Full Text] [Related]
36. Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis.
Divya T; Dineshbabu V; Soumyakrishnan S; Sureshkumar A; Sudhandiran G
Chem Biol Interact; 2016 Feb; 246():52-62. PubMed ID: 26768587
[TBL] [Abstract][Full Text] [Related]
37. KLF2 attenuates bleomycin-induced pulmonary fibrosis and inflammation with regulation of AP-1.
Shi J; Zhou LR; Wang XS; Du JF; Jiang MM; Song Z; Han GC; Mai ZT
Biochem Biophys Res Commun; 2018 Jan; 495(1):20-26. PubMed ID: 29079188
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
[TBL] [Abstract][Full Text] [Related]
39. [Effect of curcumin on the expression of collagen type I protein and transforming growth factor-beta1 mRNA in pulmonary fibrosis rats].
Chen B; Zhang DP; Gao W
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 May; 26(5):257-61. PubMed ID: 18727865
[TBL] [Abstract][Full Text] [Related]
40. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.
Wilson MS; Madala SK; Ramalingam TR; Gochuico BR; Rosas IO; Cheever AW; Wynn TA
J Exp Med; 2010 Mar; 207(3):535-52. PubMed ID: 20176803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
